Table 3 Relationship between Access to credit and medicine availability
Access to and type of credit | Stock | Odds ratios | ||
|---|---|---|---|---|
Yes n (%) | No n (%) | Crude odds ratio (95% CI) | Adjusted odds ratioa (95% CI) | |
Oral Rehydration Salts (ORS) | ||||
 No Financial Loan | 43(69) | 19(31) | 1 | 1 |
 Financial Loan | 40(67) | 20(33) | 1.03(.53–1.99) | 1.12(0.56–2.23) |
 No Stock Credit | 112(64) | 64(36) | 1 | 1 |
 Stock Credit | 60(74) | 21(26) | 1.07(0.65–1.720) | 1.22(0.60–2.50) |
Zinc dispersible Tablets | ||||
 No Financial Loan | 41(66) | 21(34) | 1 | 1 |
 Financial Loan | 30(50) | 30(50) | 0.766(.40–1.43) | 0.90(0.46–1.78) |
 No Stock Credit | 104(59) | 72(41) | 1 | 1 |
 Stock Credit | 49(60) | 32(40) | 0.95(0.60–1.50) | 1(0.50–2.0) |
Artemether Lumefantrine combined oral treatments | ||||
 No Financial Loan | 53(84) | 9(16) | 1 | 1 |
 Financial Loan | 42(70) | 18(30) | 0.46(.20–1.03) | 0.45(0.18–1.1) |
 No Stock Credit | 128(73) | 48(27) | 1 | 1 |
 Stock Credit | 60(74) | 21(26) | 1.19(0.70–2.00) | 1.9(0.77–4.8) |
Amoxicillin Dispersible tabs | ||||
 No Financial Loan | 9(16) | 53(84) | 1 | 1 |
 Financial Loan | 9(15) | 53(85) | 1.14(0.5–2.52) | 1.24(0.52–3.0) |
 No Stock Credit | 27(15) | 149(85) | 1 | 1 |
 Stock Credit | 14(17) | 67(83) | 1.28(0.72–2.27) | 1.16(0.50–2.7) |
Amoxicillin 125Â mg syrups | ||||
 No Financial Loan | 50(81) | 12(19) | 1 | 1 |
 Financial Loan | 28(47) | 32(53) | 0.47(.24–0 .89) | 0.43(0.23–0.9) |
 No Stock Credit | 105(60) | 71(40) | 1 | 1 |
 Stock Credit | 54(67) | 27(33) | 1.16(0.73–1.84) | 1(0.54–2.2) |